Gonioscopy-Assisted Transluminal Trabeculotomy Outcomes Under Different Levels of Glaucoma Severity: A Multicenter, Comparative Study

ABSTRACT

PURPOSE

To evaluate the outcomes of Gonioscopy-Assisted Transluminal Trabeculotomy (GATT) under different levels of glaucoma severity.

DESIGN

Retrospective, multicenter, before-and-after study.

METHODS

One eye from all POAG patients that underwent both Phaco-GATT or GATT stand-alone with 12 months of follow-up were included and divided according to glaucoma severity (mild – GI; moderate – GII and advanced – GIII) and the outcomes compared.

RESULTS

A total of 270 eyes were included: 90 in GI, 75 in GII and 105 in GIII. The IOP was reduced from 18.6 ± 6.0 mmHg in GI, 19.7 ± 6.4 mmHg in GII and 21.0 ± 7.9 mmHg in GIII, preoperatively, to 11.9 ± 2.6 mmHg in GI, 11.8 ± 2.1 mmHg in GII and 11.9 ± 3.0 mmHg in GIII at 12 months postoperatively (p<0.001 for all). The number of hypotensive ocular medications were reduced from 2.7 ± 1.0 in GI, 3.1 ± 0.8 in GII, and 3.2 ± 1.2 in GIII to 0.6 ± 0.9 in GI, 1.0 ± 1.1 in GII, and 1.2 ± 1.1 in GIII at the last postoperative visit (p<0.001 for all). Relative success was achieved, at one year, in 93.8% of the eyes in GI, 89.0% in GII and 88.1% in GIII (p=0.3). Complete success was achieved in 61.8% of the eyes in GI, 43.8% in GII and 37.6% in GIII (p=0.007). No serious adverse event was observed in any group.

CONCLUSIONS

GATT is a safe and effective procedure in glaucoma, regardless of its preoperative severity.